Weiß, C., Becker, L., Friese, J., Blaschek, A., Hahn, A., Illsinger, S., . . . Probst-Schendzielorz, K. (2024, December). Efficacy and safety of gene therapy with onasemnogene abeparvovec in children with spinal muscular atrophy in the D-A-CH-region: A population-based observational studyResearch in context. The Lancet Regional Health. Europe.
Chicagoスタイル(17版)引用形式Weiß, Claudia, et al. "Efficacy and Safety of Gene Therapy with Onasemnogene Abeparvovec in Children with Spinal Muscular Atrophy in the D-A-CH-region: A Population-based Observational StudyResearch in Context." The Lancet Regional Health. Europe Dec. 2024.
MLA(9版)引用形式Weiß, Claudia, et al. "Efficacy and Safety of Gene Therapy with Onasemnogene Abeparvovec in Children with Spinal Muscular Atrophy in the D-A-CH-region: A Population-based Observational StudyResearch in Context." The Lancet Regional Health. Europe, Dec. 2024.